Imatinib is not a potent anti-SARS-CoV-2 drug.
Leukemia
; 34(11): 3085-3087, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-1387182
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pyrazoles
/
Niacinamide
/
Protein Kinase Inhibitors
/
Imatinib Mesylate
/
Betacoronavirus
Type of study:
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Leukemia
Journal subject:
Hematology
/
Neoplasms
Year:
2020
Document Type:
Article
Affiliation country:
S41375-020-01045-9
Similar
MEDLINE
...
LILACS
LIS